The majority of healthcare expenditure in the United Kingdom is publicly funded through the NHS, though private household out-of-pocket and voluntary health insurance spending amounted to 47.7 billion British pounds in 2023. This statistic shows the private sector (including out-of-pocket and voluntary health insurance schemes) healthcare expenditure in the United Kingdom from 1997 to 2023.

The National Health Services (NHS) in the United Kingdom provides free universal coverage for all residents. Nevertheless, in 2022, **** percent of the population bought supplemental private insurance, this is mostly due to long waiting times in public care. This is the highest percentage reported since 2011, when a percentage of **** was also reported.

According to a survey conducted in the United Kingdom (UK) in May 2023, 47 percent of respondents mentioned that they would be unlikely to pay for private health insurance or healthcare if they needed it. On the other hand, fewer than a quarter of people said they would be likely to pay for private health insurance or private healthcare if they need it.

The percentage shares of total healthcare expenditure attributed to the public and private sectors.

Market Size and Growth: The UK health and medical insurance market is in a state of steady growth, with a projected CAGR of 4.56% from 2025 to 2033. The market size is estimated to be 8.17 million in 2025, with a value unit of millions. Key drivers behind this growth include rising healthcare costs, increased awareness of health and well-being, and the aging population. Trends and Segments: The market has witnessed several trends, including the growing popularity of private medical insurance, the emergence of healthcare cash plans, and the rise of dental insurance plans. The market is segmented based on product type (private medical insurance, healthcare cash plans, dental insurance plans) and procurement type (self-pay health coverage, employee-sponsored health coverage). Major players in the market include BUPA, AXA PPP, PT Astra Aviva Life, and Freedom Health Insurance. The report provides regional data for North America, South America, Europe, Middle East & Africa, and Asia Pacific. Publisher: [Market Research Company Name] Publish Date: [Month, Year] Number of Pages: [Number] Price: [Amount] The UK Health And Medical Insurance Market report presents a comprehensive analysis of the market including statistics, forecasts, competitive landscape, and trends. The report provides an in-depth look at the market's key segments, including product types, application, and end-user. The report also examines the market's major drivers and challenges and provides insights into the market's future prospects. Recent developments include: On November 2022, in partnership with online platform JAAQ in a six-month trial for boosting access to personalised expert-led health advice online. This adds to Bupa's mental health support which provides ongoing, around-the-clock support for a wealth of mental health conditions, such as anxiety, depression and addiction., On February 2022, AXA UK&I acquired renewable rights to Ageas UK's commercial business at an initial consideration of 47.5 million GBP. This acquisition will strengthen AXA's growth strategy and commitment to its commercial business customers and broker partnerships, particularly in the SME and Schemes market segments. As part of the agreement, around 100 Ageas UK employees will move to AXA Commercial to provide ongoing support and service delivery.. Notable trends are: Global Economic Slowdown and Better Government Insurance Services Affecting the United Kingdom Health and Medical Insurance.

This statistic displays the results of a survey on the share of respondents with private health insurance, in addition to compulsory social security in the United Kingdom in 2017, by income. Of the respondents, ** percent earning less than ** thousand British pounds reported that do not want to get private health insurance.

United Kingdom UK: Domestic Private Health Expenditure: % of Current Health Expenditure data was reported at 19.638 % in 2015. This records a decrease from the previous number of 19.675 % for 2014. United Kingdom UK: Domestic Private Health Expenditure: % of Current Health Expenditure data is updated yearly, averaging 16.913 % from Dec 2000 (Median) to 2015, with 16 observations. The data reached an all-time high of 19.813 % in 2013 and a record low of 14.803 % in 2009. United Kingdom UK: Domestic Private Health Expenditure: % of Current Health Expenditure data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s UK – Table UK.World Bank: Health Statistics. Share of current health expenditures funded from domestic private sources. Domestic private sources include funds from households, corporations and non-profit organizations. Such expenditures can be either prepaid to voluntary health insurance or paid directly to healthcare providers.; ; World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database).; Weighted average;

This statistic displays the results of a survey on the share of respondents with private health insurance in addition to compulsory social security in the United Kingdom in 2017, by region. Of respondents, ** percent living in London reported that they have private health insurance.

Revenue from private healthcare services in the United Kingdom is calculated at US$ 14.22 billion for 2024. The United Kingdom market is foreseen to register a CAGR of 2.9% and reach a value of US$ 18.74 billion by the end of 2034.

Report Attributes	Details
Revenue from Private Healthcare in United Kingdom (2024E)	US$ 14.22 Billion
Forecasted Market Value (2034F)	US$ 18.74 Billion
Demand Growth (2024 to 2034)	2.9% CAGR
Market Share of Trauma and Orthopedics Segment (2024E)	30.4%
Private Specialist Service Demand Growth (2024 to 2034)	3.5% CAGR
Key Companies Profiled	BMI Healthcare; Aspen Healthcare; Bupa Cromwell Hospital Care; Funding Circle Holdings Plc.; HCA Management Services, L.P.

Category-wise Analysis

Attribute	Private Acute Care Hospitals
Segment Value (2024E)	US$ 8.03 Billion
Growth Rate (2024 to 2034)	2.4% CAGR
Projected Value (2034F)	US$ 10.22 Billion

Attribute	Trauma and Orthopedics
Segment Value (2024E)	US$ 4.28 Billion
Growth Rate (2024 to 2034)	2.5% CAGR
Projected Value (2034F)	US$ 5.51 Billion

Total, public sector and private sector healthcare expenditure in the UK.

United Kingdom UK: Domestic Private Health Expenditure Per Capita: Current Price data was reported at 0.001 USD mn in 2015. This records a decrease from the previous number of 0.001 USD mn for 2014. United Kingdom UK: Domestic Private Health Expenditure Per Capita: Current Price data is updated yearly, averaging 0.001 USD mn from Dec 2000 (Median) to 2015, with 16 observations. The data reached an all-time high of 0.001 USD mn in 2014 and a record low of 0.000 USD mn in 2000. United Kingdom UK: Domestic Private Health Expenditure Per Capita: Current Price data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s UK – Table UK.World Bank: Health Statistics. Current private expenditures on health per capita expressed in current US dollars. Domestic private sources include funds from households, corporations and non-profit organizations. Such expenditures can be either prepaid to voluntary health insurance or paid directly to healthcare providers.; ; World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database).; Weighted average;

Independent Sector Healthcare Providers

Contains:

Ephp.csv contains parent Independent Sector Healthcare Providers (ISHPs). Note that ISHPs are considered slightly different from those organisations represented in the Non-NHS Organisations file (enonnhs.csv), in that they are confined to the large private sector healthcare companies which are contracted by the NHS, e.g. BUPA or Nuffield for. The other Non-NHS file is used for smaller private concerns which may take the odd GP referral, such as hypnotherapists.

This research was about the expansion and changing face of private sector hospital care and related diagnostic services through an organised, and increasingly transnational, healthcare industry. The research team was composed of social scientists from King's College London and public health researchers and health rights activists from India. To explore this issue, we constructed a detailed case study of the sector in Maharashtra State, India which has many expanding healthcare hubs. We interviewed a wide range of medical practitioners, managers, facility owners, regulators, policy makers, patient organisations and health rights advocates, in order to examine the implications of these emerging forms of healthcare delivery and their business and management practices for the healthcare sector, for medical practitioners and for healthcare users.

Initially this data is collected during a patient's time at hospital as part of the Commissioning Data Set (CDS). This is submitted to NHS Digital for processing and is returned to healthcare providers as the Secondary Uses Service (SUS) data set and includes information relating to payment for activity undertaken. It allows hospitals to be paid for the care they deliver. This same data can also be processed and used for non-clinical purposes, such as research and planning health services. Because these uses are not to do with direct patient care, they are called 'secondary uses'. This is the SUS data set. SUS data covers all NHS Clinical Commissioning Groups (CCGs) in England, including: • private patients treated in NHS hospitals • patients resident outside of England • care delivered by treatment centres (including those in the independent sector) funded by the NHS Each SUS record contains a wide range of information about an individual patient admitted to an NHS hospital, including: • clinical information about diagnoses and operations • patient information, such as age group, gender and ethnicity • administrative information, such as dates and methods of admission and discharge • geographical information such as where patients are treated and the area where they live NHS Digital apply a strict statistical disclosure control in accordance with the NHS Digital protocol, to all published SUS data. This suppresses small numbers to stop people identifying themselves and others, to ensure that patient confidentiality is maintained.

Who SUS is for SUS provides data for the purpose of healthcare analysis to the NHS, government and others including:

The Secondary Users Service (SUS) database is made up of many data items relating to A&E care delivered by NHS hospitals in England. Many of these items form part of the national Commissioning Data Set (CDS), and are generated by the patient administration systems within each hospital. • national bodies and regulators, such as the Department of Health, NHS England, Public Health England, NHS Improvement and the CQC • local Clinical Commissioning Groups (CCGs) • provider organisations • government departments • researchers and commercial healthcare bodies • National Institute for Clinical Excellence (NICE) • patients, service users and carers • the media

Uses of the statistics The statistics are known to be used for: • national policy making • benchmarking performance against other hospital providers or CCGs
• academic research • analysing service usage and planning change • providing advice to ministers and answering a wide range of parliamentary questions • national and local press articles • international comparison More information can be found at https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/hospital-episode-statistics https://digital.nhs.uk/data-and-information/publications/statistical/hospital-accident--emergency-activity"

In 2022, spending on private/voluntary healthcare accounted for **** percent of GDP. The share has generally increased since 2000 when private/voluntary healthcare spending was just **** percent of GDP. This statistic displays the annual spending on private (voluntary) healthcare as a share of GDP in the United Kingdom from 2000 to 2022.

Total, current and capital healthcare expenditure in the UK.

This is a monthly report on publicly funded community services for people of all ages using data from the Community Services Data Set (CSDS) reported in England for June 2022. It has been developed to help achieve better outcomes and provide data that will be used to commission services in a way that improves health, reduces inequalities, and supports service improvement and clinical quality. This report uses the new version of the dataset, CSDS v1.5. As an uplift from v1.0, the v1.5 dataset collects additional data on a person's care plan details, employment status and social and personal circumstances. These statistics are classified as experimental and should be used with caution. Experimental statistics are new official statistics undergoing evaluation. More information about experimental statistics can be found on the UK Statistics Authority website. A provisional data file for July 2022 is now included in this publication. Please note this is intended as an early view until providers submit a refresh of their data, which will be published next month. Due to the coronavirus illness (COVID-19) disruption, the quality and coverage of some of our statistics has been affected, therefore, data should be interpreted with care over the COVID-19 period.

The private healthcare market heavily drives the medical malpractice insurance industry. Under the Medical Act 1883, all healthcare professionals practising in the UK must hold clinical negligence cover. Insurers' revenue has increased at a compound annual rate of 2.3% over the five years through 2025-26. Given the nature of medical practice insurance, it's no surprise insurers contend with intense competition from state indemnity cover, and stringent regulatory hurdles. A surge in private healthcare demand, fuelled by record NHS waiting lists which reached 7.8 million in 2024, per NHS England, and growing dissatisfaction with the public health system is boosting malpractice policy volumes. High-growth areas like orthopaedics, gynaecology, and ENT are driving increased liability exposure as insurers underwrite more private procedures. Simultaneously, telehealth’s expansion brings new risk profiles, prompting insurers like AXA and Beazley to develop tailored virtual care coverage. Private cosmetic surgery, largely unregulated, is booming. Self-pay trends and NHS outsourcing, which now covers 10% of elective surgeries, widens the insured pool, while legal rulings affirms that medical liability rests with private providers, not NHS commissioners. This exposes insurers to more fragmented and risk-laden providers. Claims volumes are rising, with continued growth reported fuelled by greater legal access, patient awareness and “no win, no fee” models. Claims inflation hit 12% in 2023, according to Clyde & Co, driven by care costs, wage growth and personal injury discount rate (PIDR) changes. Social inflation and landmark rulings are expanding liability scope. In response, insurers are tightening underwriting, raising premiums and applying sub-limits. Rising legal and expert fees further erode margins, though recent FRC reforms may ease cost pressures. The sector faces a balancing act between sustainability and practitioner access. In 2025-26, revenue is expected to reach £1.8 billion, while profit is anticipated to hit 10.1%, boosted by data backed underwriting and investment income. Insurers' revenue is forecast to expand at a compound annual rate of 5.9% to £2.4 billion over the five years to 2030-31, while the average industry profit margin will reach 9.7%. Growing dissatisfaction with NHS waiting times is expected to divert patients to the private sector. Similarly, evolving legal precedent and social attitudes will likely pump up the probability of medical malpractice litigation and support sales as medical professionals seek additional coverage. Despite the industry's positive outlook, captive insurers are rising as a threat and legislative changes are expected to be key focus points over the outlook period.

Hospital Episode Statistics (HES) is a database containing details of all admissions, A and E attendances and outpatient appointments at NHS hospitals in England.

Initially this data is collected during a patient's time at hospital as part of the Commissioning Data Set (CDS). This is submitted to NHS Digital for processing and is returned to healthcare providers as the Secondary Uses Service (SUS) data set and includes information relating to payment for activity undertaken. It allows hospitals to be paid for the care they deliver.

This same data can also be processed and used for non-clinical purposes, such as research and planning health services. Because these uses are not to do with direct patient care, they are called 'secondary uses'. This is the HES data set.

• HES data covers all NHS Clinical Commissioning Groups (CCGs) in England, including:
• private patients treated in NHS hospitals
• patients resident outside of England care delivered by treatment centres (including those in the independent sector) funded by the NHS

Each HES record contains a wide range of information about an individual patient admitted to an NHS hospital, including:

clinical information about diagnoses and operations

patient information, such as age group, gender and ethnicity

administrative information, such as dates and methods of admission and discharge

geographical information such as where patients are treated and the area where they live

We apply a strict statistical disclosure control in accordance with the NHS Digital protocol, to all published HES data. This suppresses small numbers to stop people identifying themselves and others, to ensure that patient confidentiality is maintained. https://digital.nhs.uk/data-and-information/publications/statistical/hospital-accident--emergency-activity